Nanoparticle clearance is governed by Th1/Th2 immunity and strain background

Area of Science:

• Biomedical Engineering
• Immunology
• Nanotechnology

Background:

• Extended circulation of nanoparticles is crucial for clinical use but is limited by rapid clearance by the mononuclear phagocyte system (MPS).
• Current methods like polyethylene glycol (PEGylation) improve circulation but clearance mechanisms remain unclear.
• Understanding nanoparticle clearance is vital for developing effective nanomedicines.

Purpose of the Study:

• To develop and utilize an intravital microscopy assay to quantify nanoparticle clearance.
• To investigate the influence of mouse strain and immune system function on nanoparticle clearance rates.
• To elucidate the cellular mechanisms underlying nanoparticle clearance differences.

Main Methods:

• Development of an intravital microscopy-based assay for real-time nanoparticle clearance quantification.
• Comparison of nanoparticle clearance in different mouse strains with varying immune profiles (Th1 vs. Th2).
• Cell depletion strategies (granulocytes, macrophages) and in vitro macrophage uptake assays, including cytokine-induced differentiation (M1/M2).

Main Results:

• Th2-prone mouse strains exhibited significantly faster nanoparticle clearance compared to Th1-prone strains.
• Both macrophages and granulocytes were implicated in the enhanced clearance observed in Th2-prone mice.
• In vitro studies showed reduced particle uptake by macrophages from Th1 strains, which was enhanced by M2 differentiation; conversely, M1 differentiation of Th2 macrophages reduced uptake.

Conclusions:

• Mouse strain and immune response type (Th1/Th2) profoundly affect nanoparticle blood circulation times.
• Macrophages and granulocytes play key roles in immune-mediated nanoparticle clearance.
• Immune regulation strategies, particularly macrophage polarization, offer potential for controlling nanoparticle pharmacokinetics, with implications for human applications.